Evidence map›Paper›PMID 23413042›Full record

ArticleInflammation2013

Comprehensive profiling of peripheral immune cells and subsets in patients with intermittent allergic rhinitis compared to healthy controls and after treatment with glucocorticoids.

Huan Zhang, Lars Olaf Cardell, Janne Bjorkander, Mikael Benson, Hui Wang

Abstract readControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Inflammation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Reduced CD4Frontiers in immunology · 2020
    Article
  3. Review
  4. Alterations on peripheral blood B cell subsets induced by allergic rhinitis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Huan ZhangDepartment of Clinical and Experimental Medicine, Faculty of Health Sciences, Linkoping University, Linkoping, 58185, Sweden.
Lars Olaf Cardell
Janne Bjorkander
Mikael Benson
Hui Wang
Linköping University · SEKarolinska Institutet · SERyhov Hospital Jönköping · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intermittent allergic rhinitis (IAR) is a common allergic disease, which is associated with local infiltration of T cells, eosinophils, and basophils. However, changes of circulating inflammatory cells may reflect local and systemic allergic inflammation and potentially, also the response to treatment with glucocorticoids (GCs). In this study, we comprehensively profiled peripheral blood immune cells and subsets from 12 patients with IAR during the birch pollen season before and after GC treatment and nine healthy controls by flow cytometry. Orthogonal partial least squares discriminant analysis (OPLS-DA) identified that peripheral immune cells and subsets markedly separated symptomatic patients and controls. Eosinophils, basophils, and Th2 cells contributed most to the separation. However, there was no good separation between patients before and after GC treatment. Local allergic inflammation in the nasal mucosa is associated with increased circulating Th2 cells, eosinophils, and basophils. Local GC treatment has limited effects on circulating immune cells.

Indexed as

AdolescentAdultBasophilsBetulaCase-Control StudiesEosinophilsFemaleGlucocorticoidsHumansLeukocytes, MononuclearMaleMiddle AgedNasal MucosaRhinitis, Allergic, SeasonalTh2 CellsYoung AdultGlucocorticoids

Identifiers

PMID23413042
OpenAlexW2156972750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.